Andera Partners
Also known as ANDERA PARTNERS SAS
Paris multi-strategy private capital firm: life-sciences venture (€15–60m), small/mid-cap buyout (Expansion, MidCap), sponsorless mezzanine (Acto), green infrastructure and co-investment.
- HEADQUARTERS
- Paris, France
- FOUNDED
- —
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 7 people
Focus
- STAGES
- Series ASeries BGrowthBuyout
- SECTORS
- Biotech & Life SciencesHealthTechIndustrial & ManufacturingSoftware & SaaSClimate & EnergyConsumer & E-commerce
- ASSET MIX
- Private equityVenture capitalPrivate credit
- GEOGRAPHY
- EuropeUnited States
Overview
Andera Partners is a Paris-based private equity asset manager that says it has backed 377 companies in Europe and the United States over more than 20 years and employs 131 people. It runs separate strategies: andera Life Sciences (€15–60m equity in therapeutic and medtech companies in Europe and the US), andera Expansion (€15–40m) and andera MidCap (€40–120m) for European SMEs and mid-caps with €10–500m revenue, andera Acto (€10–150m sponsorless mezzanine), andera Co-Invest (€10–20m) and andera Infra (€10–40m in green infrastructure, €1–5m via Terra Nea). It has offices outside France including Germany, with a Frankfurt office opened in September 2026.
Investment thesis
Supports organic and external growth, internationalisation and governance of growing companies; Expansion backs primary growth LBOs in niche industries and B2B services, and Life Sciences invests in therapeutic and medical innovation.
PORTFOLIO (12)
- BioptimusNOTABLEArtificial Intelligence · since 2025
- TubulisNOTABLEBiotech & Life Sciences · Acquired (Gilead, 2026)
- SotraluIndustrial & Manufacturing · since 2026
- Sabena AerospaceIndustrial & Manufacturing · since 2026
- Plasseraud IPIndustrial & Manufacturing · since 2026
- Rivermark MedicalHealthTech · since 2026
- exceet Card GroupIndustrial & Manufacturing · since 2026
- Alveus TherapeuticsBiotech & Life Sciences · since 2026
- Spiro MedicalHealthTech · since 2026
- HighLifeHealthTech
- Adler OrthoHealthTech · since 2025
- XeliansSoftware & SaaS · since 2025
People
- David RobinPartner in charge of Andera Expansion · source
- Olivier Le GallPartner, Andera Expansion · source
- Léopold BrichardPartner, Andera Expansion · source
- Mayeul CaronPartner, Andera Expansion · source
- Stéphane BergezPartner, Head of Andera Acto · source
- Aneta SottilPartner (Life Sciences) · source
- Olivier LitzkaPartner, Andera Life Sciences · source
Links
Frequently asked questions
Andera Partners is a private equity fund based in Paris, France.
Yes. Andera Partners invests its own capital in private companies.
Andera Partners invests at Series A, Series B, Growth and Buyout stages in Biotech & Life Sciences, HealthTech, Industrial & Manufacturing, Software & SaaS, Climate & Energy and Consumer & E-commerce.
Andera Partners's stated ticket size is €10M–€150M.
Key people at Andera Partners include David Robin (Partner in charge of Andera Expansion), Olivier Le Gall (Partner, Andera Expansion), Léopold Brichard (Partner, Andera Expansion) and Mayeul Caron (Partner, Andera Expansion).
Andera Partners's investments include Bioptimus, Tubulis, Sotralu, Sabena Aerospace, Plasseraud IP, Rivermark Medical, exceet Card Group and Alveus Therapeutics, among others.
The most recent publicly reported investment by Andera Partners is Sotralu (Buyout (majority, Andera Expansion)), announced in Sep 2026.
Yes. Andera Partners manages capital from outside investors.